Answers are grounded in this paper and cite their sources.
Subarachnoid hemorrhage (SAH) induces robust neuroinflammation, characterized by rapid activation of innate immune cells and subsequent engagement of adaptive immunity. The transmembrane adaptor protein SLP adaptor and C-terminal Src kinase-interacting membrane protein (SCIMP) has emerged as a critical regulator of immune signaling in microglia and antigen-presenting cells. SCIMP interacts with Toll-like receptors (TLRs) and recruits Lyn kinase, forming the SCIMP-TLR-Lyn signaling axis that fine-tunes downstream inflammatory cascades. Activation of this axis modulates cytokine production, balancing pro and anti-inflammatory responses, and influences antigen presentation to T cells, thereby shaping adaptive immune activation. Experimental models of SAH demonstrate that SCIMP deficiency exacerbates neuroinflammation, disrupts the blood-brain barrier, and worsens neurological outcomes, whereas SCIMP activation attenuates inflammatory injury and promotes tissue recovery. These findings highlight the SCIMP-TLR-Lyn pathway as a pivotal mediator of both innate and adaptive immunomodulation after SAH and suggest its potential as a therapeutic target for mitigating secondary brain injury.
No takes yet. Share an insight, caveat, or question.
Islam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: